Med-Pro
Med-Pro Brand names, Med-Pro Analogs
- Amen
- Aragest
- Aragest 5
- Asconale
- Clinofem
- Clinovir
- Colirest
- Crinone
- Curretab
- Cycrin
- DMPA
- Depo-Clinovir
- Depo-Prodasone
- Depo-Progestin
- Depo-Promone
- Depo-Provera
- Depo-Subq Provera 104
- Depomedroxyprogesterone acetate
- Depot-Medroxyprogesterone acetate
- Farlutal
- Farlutin
- G-Farlutal
- Gestapuran
- Hematrol
- Hydroxymethylprogesterone
- Hysron
- Indivina
- Lunelle
- Lutopolar
- Lutoral
- MAP
- MPA
- Med-Pro
- Medroprogesterone Acetate
- Medrossiprogesterone [Dcit]
- Medroxiprogesterona [Inn-Spanish]
- Medroxiprogesteronum
- Medroxyprogesteron
- Medroxyprogesteron acetate
- Medroxyprogesterone acetate
- Medroxyprogesterone Base
- Medroxyprogesteronum [Inn-Latin]
- Meprate
- Metigestrona
- MPA Gyn 5
- Nadigest
- Nidaxin
- Novo-Medrone
- Oragest
- Perlutex
- Perlutex Leo
- Prempro/Premphase
- Prodasone
- Progestalfa
- Progestasert
- Progesterone
- Progeston
- Progevera
- Prometrium
- Provera
- Proverone
- Ralovera
- Repromap
- Repromix
- Sirprogen
- Sodelut G
- Veramix
Med-Pro Brand Names Mixture
- Lunelle (Medroxyprogesterone + Estradiol)
Med-Pro Chemical_Formula
C22H32O3
Med-Pro RX_link
http://www.rxlist.com/cgi/generic/medrox.htm
Med-Pro fda sheet
Med-Pro msds (material safety sheet)
Med-Pro Synthesis Reference
P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)
Med-Pro Molecular Weight
344.488 g/mol
Med-Pro Melting Point
220 - 223.5 oC
Med-Pro H2O Solubility
22.2mg/L
Med-Pro State
Solid
Med-Pro LogP
3.606
Med-Pro Dosage Forms
Tablets; Depo injection
Med-Pro Indication
Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.
Med-Pro Pharmacology
Medroxyprogesterone is a synthetic progestin more potent than progesterone.
Med-Pro Absorption
Rapidly absorbed from GI tract
Med-Pro side effects and Toxicity
Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.
Med-Pro Patient Information
Med-Pro Organisms Affected
Humans and other mammals
